Find Research outputs

Search results

• 2018

  Parent-child genetic testing for familial hypercholesterolaemia in an Australian context

  Pang, J., Martin, A. C., Bates, T. R., Hooper, A. J., Bell, D. A., Burnett, J. R., Norman, R. & Watts, G. F., Jul 2018, In : Journal of Paediatrics and Child Health. 54, 7, p. 741-747

  Research output: Contribution to journal › Article

  • Hyperlipoproteinemia Type II
  • Genetic Testing
  • LDL Cholesterol
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Child
  8 Citations (Scopus)
• 2019

  A window into the heart of familial hypercholesterolaemia in the community

  Watts, G. F. & Pang, J., 1 May 2019, In : The Lancet Public Health. 4, 5, p. e216-e217

  Research output: Contribution to journal › Editorial

  Open Access
• 2018

  Homozygous familial hypercholesterolaemia in Vietnam: Case series, genetics and cascade testing of families

  Truong, T. H., Kim, N. T., Nguyen, M. N. T., Pang, J., Hooper, A. J., Watts, G. F. & Do, D. L., Oct 2018, In : Atherosclerosis. 277, p. 392-398 7 p.

  Research output: Contribution to journal › Article

  • Hyperlipoproteinemia Type II
  • Vietnam
  • Genetic Testing
  • LDL Receptors
  • Mutation
  7 Citations (Scopus)
• 2019

  Effect of Lipoprotein(a) on the Diagnosis of Familial Hypercholesterolemia: Does it Make a Difference in the Clinic?

  Chan, D. C., Pang, J., Hooper, A. J., Bell, D. A., Burnett, J. R. & Watts, G. F., Oct 2019, In : Clinical Chemistry. 65, 10, p. 1258-1266

  Research output: Contribution to journal › Article

  • Hyperlipoproteinemia Type II
  • Lipoprotein(a)
  • LDL Cholesterol
  • Cholesterol
  • Lipids
  9 Citations (Scopus)
• 2018

  Elevated lipoprotein(a) and familial hypercholesterolemia in the coronary care unit: Between Scylla and Charybdis

  Ellis, K. L., Pang, J., Chieng, D., Bell, D. A., Burnett, J. R., Schultz, C. J., Hillis, G. S. & Watts, G. F., Mar 2018, In : Clinical Cardiology. 41, 3, p. 378-384

  Research output: Contribution to journal › Article

  • Coronary Care Units
  • Hyperlipoproteinemia Type II
  • Lipoprotein(a)
  • Coronary Artery Disease
  • Acute Coronary Syndrome
  13 Citations (Scopus)

• Elevated lipoprotein(a) and low-density lipoprotein cholesterol as predictors of the severity and complexity of angiographic lesions in patients with premature coronary artery disease

  Chieng, D., Pang, J., Ellis, K. L., Hillis, G. S., Watts, G. F. & Schultz, C. J., 3 Apr 2018, In : Journal of Clinical Lipidology. 12, 4, p. 1019-1026

  Research output: Contribution to journal › Article

  • Lipoprotein(a)
  • LDL Cholesterol
  • Coronary Artery Disease
  • Coronary Care Units
  • Hyperlipoproteinemia Type II
  12 Citations (Scopus)
• 2020

  Coronary artery disease and the risk-associated LPA variants, rs3798220 and rs10455872, in patients with suspected familial hypercholesterolaemia

  Page, M. M., Ellis, K. L., Pang, J., Chan, D. C., Hooper, A. J., Bell, D. A., Burnett, J. R. & Watts, G. F., 1 Nov 2020, In : Clinica Chimica Acta. 510, p. 211-215

  Research output: Contribution to journal › Article

  • Hyperlipoproteinemia Type II
  • Lipoprotein(a)
  • Polymorphism
  • Coronary Artery Disease
  • Single Nucleotide Polymorphism
• 2018

  Heterozygous familial hypercholesterolaemia in specialist centres in South Africa, Australia and Brazil: Importance of early detection and lifestyle advice

  Pang, J., David Marais, A., Blom, D. J., Brice, B. C., Silva, P. R., Jannes, C. E., Pereira, A. C., Hooper, A. J., Ray, K. K., Santos, R. D. & Watts, G. F., Oct 2018, In : Atherosclerosis. 277, p. 470-476 7 p.

  Research output: Contribution to journal › Article

  • South Australia
  • Hyperlipoproteinemia Type II
  • South Africa
  • Brazil
  • Life Style
  2 Citations (Scopus)

• Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

  EAS Familial Hypercholesterolaemia Studies Collaboration, the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) Investigators & Pang, J., 1 Oct 2018, In : Atherosclerosis. 277, p. 234-255 22 p.

  Research output: Contribution to journal › Article

  • Hyperlipoproteinemia Type II
  • Registries
  • Government Programs
  • Research Personnel
  • Knowledge Management
  60 Citations (Scopus)
• 2020

  The Knowns and Unknowns of Contemporary Statin Therapy for Familial Hypercholesterolemia

  Pang, J., Chan, D. C. & Watts, G. F., Nov 2020, In : Current Atherosclerosis Reports. 22, 11, 64.

  Research output: Contribution to journal › Review article

  • Hyperlipoproteinemia Type II
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Therapeutics
  • Cardiovascular Diseases
  • LDL Cholesterol
  2 Citations (Scopus)

• Correction: Effect of Lipoprotein (a) on the Diagnosis of Familial Hypercholesterolemia: Does It Make a Difference in the Clinic?

  Chan, D., Pang, J., Hooper, A., Bell, D., Burnett, J. & Watts, G., 26 Apr 2020, In : Clinical Chemistry. 66, 5, p. 737-738

  Research output: Contribution to journal › Comment/debate
• 2019

  Comparative aspects of the care of familial hypercholesterolemia in the “Ten Countries Study”

  Pang, J., Chan, D. C., Hu, M., Muir, L. A., Kwok, S., Charng, M. J., Florkowski, C. M., George, P. M., Lin, J., Loi, D. D., Marais, A. D., Nawawi, H. M., Gonzalez-Santos, L. E., Su, T. C., Truong, T. H., Santos, R. D., Soran, H., Tomlinson, B., Yamashita, S., Ademi, Z. & 1 others, Watts, G. F., Apr 2019, In : Journal of Clinical Lipidology. 13, 2, p. 287-300

  Research output: Contribution to journal › Article

  • Hyperlipoproteinemia Type II
  • Delivery of Health Care
  • Genetic Testing
  • Education
  • Developing Countries
  12 Citations (Scopus)

• Familial Hypercholesterolaemia in 2020: A Leading Tier 1 Genomic Application

  Pang, J., Sullivan, D. R., Brett, T., Kostner, K. M., Hare, D. L. & Watts, G. F., 24 Dec 2019, In : Heart, Lung and Circulation.

  Research output: Contribution to journal › Review article

  • Hyperlipoproteinemia Type II
  • Coronary Artery Disease
  • LDL Cholesterol
  • Parturition
  • LDL Lipoproteins
  8 Citations (Scopus)
• 2020

  Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: Many happy returns on investment?

  Ademi, Z., Norman, R., Pang, J., Liew, D., Zoungas, S., Sijbrands, E., Ference, B., Wiegman, A. & Watts, G. F., Jul 2020, In : Atherosclerosis. 304, p. 1-8

  Research output: Contribution to journal › Article

  • Hyperlipoproteinemia Type II
  • Cost-Benefit Analysis
  • Costs and Cost Analysis
  • Quality-Adjusted Life Years
  • Health
  2 Citations (Scopus)

• Integrated Guidance for Enhancing the Care of Familial Hypercholesterolaemia in Australia

  FH Australasia Network Consensus Working Group, Watts, G. F., Sullivan, D. R., Hare, D. L., Kostner, K. M., Horton, A. E., Bell, D. A., Brett, T., Trent, R. J., Poplawski, N. K., Martin, A. C., Srinivasan, S., Justo, R. N., Chow, C. K., Pang, J., Ademi, Z., Ardill, J. J., Barnett, W., Bates, T. R., Beilin, L. J. & 65 others, Bishop, W., Black, J. A., Brett, P., Brown, A., Burnett, J. R., Bursill, C. A., Colley, A., Clifton, P. M., Ekinci, E. I., Elias, L., Figtree, G. A., Forge, B. H., Garton-Smith, J., Graham, D. F., Hamilton-Craig, I., Hamilton-Craig, C. R., Heal, C., Hespe, C. M., Hooper, A. J., Howes, L. G., Ingles, J., Irwin, J., Janus, E. D., Kangaharan, N., Keech, A. C., Kirke, A. B., Kritharides, L., Kyle, C. V., Lacaze, P., Lambert, K., Li, S. C. H., Malan, W., Maticevic, S., McQuillan, B. M., Mirzaee, S., Mori, T. A., Morton, A. C., Colquhoun, D. M., Moullin, J. C., Nestel, P. J., Nowak, K. J., O'Brien, R. C., Pachter, N., Page, M. M., Pedrotti, A., Psaltis, P. J., Radford, J., Reid, N. J., Robertson, E. N., Ryan, J. D. M., Sarkies, M. N., Schultz, C. J., Scott, R. S., Semsarian, C., Simons, L. A., Spinks, C., Tonkin, A. M., van Bockxmeer, F., Waddell-Smith, K. E., Ward, N. C., White, H. D., Wilson, A. M., Winship, I., Woodward, A. M. & Nicholls, S. J., 2020, (Accepted/In press) In : Heart Lung and Circulation.

  Research output: Contribution to journal › Article

  Open Access

  • Hyperlipoproteinemia Type II
  • LDL Cholesterol
  • Proprotein Convertase 9
  • Ezetimibe
  • Blood Component Removal

• Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care

  Watts, G. F., Gidding, S. S., Mata, P., Pang, J., Sullivan, D. R., Yamashita, S., Raal, F. J., Santos, R. D. & Ray, K. K., 23 Jan 2020, In : Nature Reviews Cardiology.

  Research output: Contribution to journal › Review article

  • Hyperlipoproteinemia Type II
  • Ezetimibe
  • Blood Component Removal
  • Self-Help Groups
  • Precision Medicine
  11 Citations (Scopus)
• 2019

  A cross-national investigation of cardiovascular survival in homozygous familial hypercholesterolaemia: the Sino-Roman Study

  Stefanutti, C., Pang, J., Di Giacomo, S., Wu, X., Wang, X., Morozzi, C., Watts, G. F. & Lin, J., Jul 2019, In : Journal of Clinical Lipidology. 13, 4, p. 608-617

  Research output: Contribution to journal › Article

  Open Access

  File

  • Hyperlipoproteinemia Type II
  • Blood Component Removal
  • LDL Cholesterol
  • Survival
  • Lipoproteins
  6 Citations (Scopus)

  126 Downloads (Pure)
• 2018

  Health literacy in familial hypercholesterolemia: A cross-national study

  Hagger, M. S., Hardcastle, S. J., Hu, M., Kwok, S., Lin, J., Nawawi, H. M., Pang, J., Santos, R. D., Soran, H., Su, T-C., Tomlinson, B. & Watts, G. F., Jun 2018, In : European Journal of Cardiovascular Prevention & Rehabilitation. 25, 9, p. 936-943

  Research output: Contribution to journal › Article

  Open Access

  File

  • Health Literacy
  • Hyperlipoproteinemia Type II
  • Income
  • China
  • Malaysia
  20 Citations (Scopus)

  261 Downloads (Pure)

• Simplified Canadian Definition for Familial Hypercholesterolemia

  Ruel, I., Brisson, D., Aljenedil, S., Awan, Z., Baass, A., Bélanger, A., Bergeron, J., Bewick, D., Brophy, J. M., Brunham, L. R., Couture, P., Dufour, R., Francis, G. A., Frohlich, J., Gagné, C., Gaudet, D., Grégoire, J. C., Gupta, M., Hegele, R. A., Mancini, G. B. J. & 6 others, McCrindle, B. W., Pang, J., Raggi, P., Tu, J. V., Watts, G. F. & Genest, J., 1 Sep 2018, In : Canadian Journal of Cardiology. 34, 9, p. 1210-1214 5 p.

  Research output: Contribution to journal › Article

  Open Access

  • Hyperlipoproteinemia Type II
  • LDL Cholesterol
  • Cardiovascular Diseases
  • Xanthomatosis
  • Lipids
  31 Citations (Scopus)
• 2019

  Predicting intention to participate in self-management behaviors in patients with Familial Hypercholesterolemia: A cross-national study

  Hagger, M. S., Hamilton, K., Hardcastle, S. J., Hu, M., Kwok, S., Lin, J., Nawawi, H. M., Pang, J., Santos, R. D., Soran, H., Su, T., Tomlinson, B. & Watts, G. F., Dec 2019, In : Social Science & Medicine. 242, 112591.

  Research output: Contribution to journal › Article
  3 Citations (Scopus)
• 2018

  Nutraceuticals in the management of patients with statin-associated muscle symptoms, with a note on real-world experience

  Ward, N. C., Pang, J., Ryan, J. D. M. & Watts, G. F., 24 Jan 2018, In : Clinical Cardiology. 41, 1, p. 159-165

  Research output: Contribution to journal › Review article

  Open Access

  • Dietary Supplements
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • LDL Cholesterol
  • Muscles
  • Cardiovascular Diseases
  11 Citations (Scopus)
• 2020

  PCSK9 Inhibition with alirocumab increases the catabolism of lipoprotein(a) particles in statin-treated patients with elevated lipoprotein(a)

  Watts, G. F., Chan, D. C., Pang, J., Ma, L., Ying, Q., Aggarwal, S., Marcovina, S. M. & Barrett, P. H. R., Jun 2020, In : Metabolism. 107, 154221.

  Research output: Contribution to journal › Article

  • alirocumab
  • Proprotein Convertase 9
  • Apoprotein(a)
  • Lipoprotein(a)
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  2 Citations (Scopus)

• Very special case of primary prevention with statins

  Pang, J., Martin, A. & Watts, G., 20 Apr 2020, In : Journal of Paediatric and Child Health. 56, 4, p. 656

  Research output: Contribution to journal › Editorial
• 2019

  Familial hypercholesterolaemia: a common cause of premature coronary disease in the community and a paradigm for the practice of precision medicine

  Pang, J. & Watts, G., 2019, In : Tasman Medical Journal. 1, 2, p. 16-26

  Research output: Contribution to journal › Review article

  • Hyperlipoproteinemia Type II
  • Precision Medicine
  • Coronary Disease
  • Proprotein Convertase 9
  • Genetic Testing
• 2018

  A comparative analysis of phenotypic predictors of mutations in familial hypercholesterolemia

  Chan, D. C., Pang, J., Hooper, A. J., Bell, D. A., Bates, T. R., Burnett, J. R. & Watts, G. F., 1 Apr 2018, In : The Journal of clinical endocrinology and metabolism. 103, 4, p. 1704-1714

  Research output: Contribution to journal › Article

  Open Access

  File

  • Hyperlipoproteinemia Type II
  • Lipids
  • Xanthomatosis
  • Early Diagnosis
  • Mutation
  19 Citations (Scopus)

  734 Downloads (Pure)
• 2020

  Gaps in the Care of Familial Hypercholesterolaemia in Australia: First Report From the National Registry

  Members of the FH Australasia Network Registry, Pang, J., Sullivan, D. R., Hare, D. L., Colquhoun, D. M., Bates, T. R., Ryan, J. D. M., Bishop, W., Burnett, J. R., Bell, D. A., Simons, L. A., Mirzaee, S., Kostner, K. M., Nestel, P. J., Wilson, A. M., O'Brien, R. C., Janus, E. D., Clifton, P. M., Ardill, J. J., Chan, D. C. & 2 others, van Bockxmeer, F. & Watts, G. F., 29 Aug 2020, In : Heart Lung and Circulation.

  Research output: Contribution to journal › Article

  • Hyperlipoproteinemia Type II
  • Registries
  • LDL Cholesterol
  • Lipids
  • Australasia

• The economic impact of familial hypercholesterolemia on productivity

  Ademi, Z., Marquina, C., Zomer, E., Bailey, C., Owen, A., Pang, J., Norman, R., Watts, G. F. & Liew, D., 2020, In : Journal of Clinical Lipidology. 14, 6, p. 799-806.e3

  Research output: Contribution to journal › Article

  • Hyperlipoproteinemia Type II
  • Quality-Adjusted Life Years
  • Economics
  • Gross Domestic Product
  • Life Tables
  1 Citation (Scopus)

• An age-matched computed tomography angiographic study of coronary atherosclerotic plaques in patients with familial hypercholesterolaemia

  Pang, J., Abraham, A., Vargas-García, C., Bates, T. R., Chan, D. C., Hooper, A. J., Bell, D. A., Burnett, J. R., Schultz, C. J. & Watts, G. F., Apr 2020, In : Atherosclerosis. 298, p. 52-57 6 p.

  Research output: Contribution to journal › Article

  • Hyperlipoproteinemia Type II
  • Atherosclerotic Plaques
  • Coronary Vessels
  • Tomography
  • Coronary Artery Disease
  2 Citations (Scopus)

• Design, development and deployment of a web-based patient registry for rare genetic lipid disorders

  Napier, K. R., Hooper, A. J., Ng, D. M., Render, L., Bell, D. A., Pang, J., Watts, G. F., Bellgard, M. I. & Burnett, J. R., 7 Apr 2020, In : Pathology.

  Research output: Contribution to journal › Article

  • Inborn Genetic Diseases
  • Registries
  • Lipids
  • Hyperlipoproteinemia Type II
  • Rare Diseases
  1 Citation (Scopus)

• Lipoprotein(a) in Patients With Type 2 Diabetes and Premature Coronary Artery Disease in the Coronary Care Unit

  Lan, N. S. R., Chan, D. C., Pang, J., Fegan, P. G., Yeap, B. B., Rankin, J. M., Schultz, C. J., Watts, G. F. & Bell, D. A., 12 Nov 2020, In : Heart, Lung & Circulation.

  Research output: Contribution to journal › Article

  • Coronary Care Units
  • Lipoprotein(a)
  • Coronary Artery Disease
  • Type 2 Diabetes Mellitus
  • Acute Coronary Syndrome
• 2018

  Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia

  Hagger, M. S., Hardcastle, S. J., Hu, M., Kwok, S., Lin, J., Nawawi, H. M., Pang, J., Santos, R. D., Soran, H., Su, T-C., Tomlinson, B. & Watts, G. F., Oct 2018, In : Atherosclerosis. 277, p. 493-501 9 p.

  Research output: Contribution to journal › Article

  • Hyperlipoproteinemia Type II
  • Prescription Drug Overuse
  • Intention
  • Cholesterol
  • Psychological Models
  12 Citations (Scopus)
• 2020

  Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action

  Representatives of the Global Familial Hypercholesterolemia Community, 2 Jan 2020, In : JAMA Cardiology.

  Research output: Contribution to journal › Article

  • Hyperlipoproteinemia Type II
  • Public Health
  • Cardiology
  • Registries
  • Cardiovascular Diseases
  36 Citations (Scopus)
• 2019

  A genetic risk score predicts coronary artery disease in familial hypercholesterolaemia: enhancing the precision of risk assessment

  Ellis, K. L., Hooper, A. J., Pang, J., Chan, D. C., Burnett, J. R., Bell, D. A., Schultz, C. J., Moses, E. K. & Watts, G. F., 30 Sep 2019, In : Clinical Genetics.

  Research output: Contribution to journal › Article

  Open Access

  File

  • Hyperlipoproteinemia Type II
  • Risk Assessment
  • Coronary Artery Disease
  • Life Style
  • Coronary Vessels
  3 Citations (Scopus)

  162 Downloads (Pure)